CASTLE BIOSCIENCES INC·4

Jun 18, 4:19 PM ET

Oelschlager Kristen M 4

4 · CASTLE BIOSCIENCES INC · Filed Jun 18, 2026

Research Summary

AI-generated summary of this filing

Updated

Castle Biosciences (CSTL) COO Kristen Oelschlager Sells 8,587 Shares

What Happened

  • Kristen M. Oelschlager, Chief Operating Officer of Castle Biosciences (CSTL), disposed of 8,587 shares in an open-market sale on June 16, 2026. The weighted-average sale price was $20.71 per share for total proceeds of about $177,837. The sale is reported with code "S" (sale).

Key Details

  • Transaction date: June 16, 2026; Form 4 filed June 18, 2026 (timely filing).
  • Price details: executed in multiple trades at prices ranging $20.51–$20.95; $20.71 is the weighted-average sale price. The reporting person can provide the full trade-by-trade breakdown on request. (Footnote F2)
  • Plan/authorization: Transactions were made pursuant to a Rule 10b5-1 trading plan adopted March 17, 2026. (Footnote F1)
  • Ownership vehicle: Shares were held by the Fritz Shorter Trust, of which the reporting person and her spouse are trustees and beneficiaries. (Footnote F3)
  • Shares owned after the transaction: not stated in the provided filing excerpt.

Context

  • Sales executed under Rule 10b5-1 plans are typically prearranged and scheduled; they do not necessarily reflect the insider’s current view of the company. This was a straightforward open-market sale of trust-held shares rather than an option exercise, gift, or award.

Insider Transaction Report

Form 4
Period: 2026-06-16
Oelschlager Kristen M
Chief Operating Officer
Transactions
  • Sale

    Common Stock

    [F1][F2]
    2026-06-16$20.71/sh8,587$177,83730,460 total
Holdings
  • Common Stock

    [F3]
    (indirect: By Trust)
    97,251
Footnotes (3)
  • [F1]These transactions were made pursuant to a Rule 10b5-1 plan adopted by the Reporting Person, on March 17, 2026.
  • [F2]This transaction was executed in multiple trades at prices ranging from $20.51 to $20.95, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  • [F3]Held by the Fritz Shorter Trust of which the Reporting Person and her spouse are the trustees and beneficiaries.
Signature
/s/ Frank Stokes, Attorney-in-fact|2026-06-18

Documents

1 file
  • 4
    wk-form4_1781813983.xmlPrimary

    FORM 4